EDGAR Filing Documents for 9999999995-17-002332

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-17-002332

Accepted

2017-09-13 00:15:11

Documents

Effectiveness Date

2017-09-12

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	596
	Complete submission text file	9999999995-17-002332.txt		1730

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152

Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538

Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)